EUCTR2011-002739-24-DK进行中（未招募）不适用
Does the GLP-1 receptor agonist (Victoza®) improve the metabolic response to physical training in patients with type 2 diabetes?
Dr. med. Tina Vilsbøll0 个研究点开始时间: 2011年8月26日最近更新:
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Informed oral and written consent
- •Diagnosed with type 2 diabetes according to the criteria of the WHO
- •(see appendix 5)
- •HbA1C: 7-10% (doing treatment with diet and/or metformin)
- •Age >18 years
- •BMI >25 kg/m2 <35 kg/m2
- •Negative islet cell antibodies (ICA) and glutamatsyre decarboxylase 65
- •(GAD-65) autoantibodies
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 30
排除标准
- •Females of child bearing potential who are pregnant, breast-feeding or
- •have intention of becoming pregnant or are not using adequate
- •contraceptive measures.
- •Subjects treated with sulfonylurinstof, dipeptidyl peptidase 4 (DPP-4)
- •inhibitors, insulin or glitazoner
- •Ongoing abuse of alcohol or narcotics
- •Impaired hepatic function (liver transaminases >2 times upper normal
- •Impaired renal function (se-creatinine >150µM and/or albuminuria)
- •XML File Identifier: POxD9P5KKuNPnWUv/kBDFfkMsD0=
- •Cardic problems defined as decompensated heart failure (NYHA class
- •III or IV), unstable angina pectoris and/or myocardial infarction within
- •the last 12 months (see appendix 6)
- •Uncontrolled hypertension (systolic blood pressure >180 mmHg,
- •diastolic blood pressure >100 mmHg)
- •Any condition that the investigators feels would interfere with trial
- •participation
- •Receiving any investigational drug within the last 3 months
- •Compliance <80% to training
研究者
相似试验
已完成
4 期
The Effects of Physical Training and GLP-1 Receptor Agonist Liraglutide Treatment in Patients With Type 2 DiabetesType 2 DiabetesNCT01455441Tina Vilsboll40
已完成
不适用
Impact of Liraglutide on Sensory Perception, Sensory Specific Satiety, Liking and Wanting in Type 2 Diabetic PatientsOverweightType 2 Diabetes MellitusNCT01599338Centre Hospitalier Universitaire Dijon30
已完成
不适用
Glucagon-like peptide-1 receptor agonists decrease cancer incidences in type 2 diabetes: A cohort study using the database of Health Insurance Claims and Specific Health Checkups of Gifu and Mie Prefecture in JapaType2 diabetesJPRN-UMIN000051278Kimitsu Chuo Hospital356,266
已完成
不适用
The efficacy of GLP-1 receptor agonist on glycemic control in type 2 diabetes with inadequate DPP-4 inhibitor therapy.type 2 diabetesJPRN-UMIN000006959Department of Metabolism and Endocrinology, Juntendo Graduate University of Medicine90
招募中
1 期
TOLEDDO: Effect of weekly GLP1 agonist treatment in double diabetes: a randomized, open-label studyCTIS2024-514906-30-00Centre Hospitalier Universitaire De Dijon76